Peter Virsik
Director de Operaciones en ESSA PHARMA INC. .
Fortuna: 75 911 $ al 31/05/2024
Perfil
Peter A.
Virsik is currently the Chief Operating Officer & Executive Vice President at ESSA Pharma, Inc. He previously worked as an Associate Director at Gilead Sciences, Inc. from 2000 to 2005 and as the Senior Vice President-Corporate Development at XenoPort, Inc. from 2005 to 2015.
Virsik received his undergraduate degree from the University of California, Berkeley, his graduate degree from the University of Michigan, and his MBA from Kellogg School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ESSA PHARMA INC
0.03% | 06/05/2024 | 11 246 ( 0.03% ) | 75 911 $ | 31/05/2024 |
Cargos activos de Peter Virsik
| Empresas | Cargo | Inicio |
|---|---|---|
| ESSA PHARMA INC. | Director de Operaciones | 01/08/2016 |
Antiguos cargos conocidos de Peter Virsik.
| Empresas | Cargo | Fin |
|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2005 |
Formación de Peter Virsik.
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Bolsa de valores
- Insiders
- Peter Virsik
